Summary
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK and PD information necessary for clients’ go/no go decisions and to determine appropriate dosing ranges in Phase II studies.
Register to download
CSF Sampling
You may also be interested in:
Capability
ECG Assessments During the Development of Oncology Compounds
Single-center oncology studies performed by dedicated PRA staff, combined with the High Precision QT approach of iCardiac, generates conclusive ECG…
View Resource
White Paper
Onsite Manufacturing Early Clinical Development
Early drug development requires adherence to Good Manufacturing Practices (GMP) guidelines when manufacturing investigational medicinal products…
View Resource
Fact Sheet
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
View Resource
View all related content and resources for Clinical Pharmacology
Explore Insights